Lantheus Balance Sheet
NASDAQ: LNTHHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Lantheus financial position
At the end of fiscal 2025, Lantheus reported total assets of $2.23 billion, up 12.5% from a year earlier against total liabilities of $1.14 billion. Shareholders' equity stood at $1.09 billion, or 48.9% of assets. The company held $359.1 million in cash and equivalents against $569.4 million of debt, a net debt position of $210.3 million.
The current ratio (current assets divided by current liabilities) was 2.70, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.52.
Summary generated from market data by MetaCap's automated system. Methodology
Lantheus balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 359.12M | 912.81M | 713.66M | 415.65M | 98.51M | 79.61M | 92.92M | 113.40M | 76.29M | 51.18M |
| Receivables | 358.64M | 321.26M | 284.29M | 213.40M | 89.34M | 54.00M | 43.53M | 43.75M | 40.26M | 36.82M |
| Inventory | 64.67M | 68.03M | 64.03M | 35.48M | 35.13M | 35.74M | 29.18M | 33.02M | 26.08M | 17.64M |
| Total Current Assets | 899.96M | 1.33B | 1.09B | 677.62M | 235.79M | 184.22M | 172.91M | 195.41M | 147.85M | 110.82M |
| Property, Plant & Equipment | 163.69M | 176.80M | 146.70M | 122.17M | 116.77M | 120.17M | 116.50M | 107.89M | 93.00M | 94.19M |
| Goodwill | 239.52M | 61.19M | 61.19M | 61.19M | 61.19M | 58.63M | 15.71M | 15.71M | 15.71M | 15.71M |
| Intangible Assets | 722.78M | 161.76M | 151.99M | 315.29M | 348.51M | 376.01M | 7.34M | 9.13M | 11.80M | 15.12M |
| Total Assets | 2.23B | 1.98B | 1.65B | 1.32B | 863.78M | 869.82M | 405.92M | 439.83M | 383.86M | 255.90M |
| Accounts Payable | 42.91M | 34.56M | 41.19M | 20.56M | 20.79M | 16.28M | 18.61M | 17.95M | 17.46M | 18.94M |
| Short-Term Debt | 738.00K | 974.00K | 823.00K | 354.00K | 11.64M | 20.70M | 10.14M | 2.75M | 2.75M | 3.65M |
| Total Current Liabilities | 333.42M | 240.53M | 187.35M | 247.70M | 90.50M | 80.50M | 66.11M | 52.76M | 46.75M | 43.84M |
| Long-Term Debt | 568.68M | 565.28M | 561.67M | 557.71M | 163.12M | 197.70M | 183.93M | 263.71M | 265.39M | 274.46M |
| Total Liabilities | 1.14B | 892.33M | 835.26M | 874.11M | 399.35M | 355.62M | 291.32M | 368.83M | 360.57M | 362.41M |
| Shareholders' Equity | 1.09B | 1.09B | 815.89M | 447.15M | 464.44M | 514.21M | 114.60M | 71.00M | 23.29M | -106.52M |
| Retained Earnings | 679.50M | 445.94M | 133.50M | -193.16M | -221.22M | -149.95M | -136.47M | -168.14M | -209.01M | -332.40M |
| Total Debt | 569.42M | 566.25M | 562.49M | 558.07M | 174.76M | 218.40M | 194.07M | 266.46M | 268.14M | 278.11M |
| Net Cash (Debt) | -210.29M | 346.56M | 151.16M | -142.41M | -76.25M | -138.79M | -101.15M | -153.06M | -191.85M | -226.93M |
| Shares Outstanding | 64.59M | 68.45M | 69.86M | 68.85M | 67.74M | 66.88M | 39.25M | 39.25M | 38.47M | 38.47M |
This table shows 10 annual periods of Lantheus's balance sheet, from FY 2025 back to FY 2016, across 18 line items including cash & equivalents, receivables, inventory. Values in USD; B = billions, M = millions. Fiscal periods follow LNTH's reporting calendar. What is a balance sheet?